Cellcom Selects Amdocs' Vubiquity to Provide TV Viewers with Personalized Content Experiences

JERSEY CITY, N.J., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Amdocs (NASDAQ: DOX), a leading provider of software and services to communications and media companies, today announced that it has been selected by Israel’s Cellcom to bring compelling new digital content to Cellcom TV viewers through Amdocs’ Vubiquity platform.

Vubiquity holds relationships with hundreds of content creators and distributors around the globe, bringing together the latest releases from major studios, leading independents, library classics and a host of genre-based categories.

Under the newly-extended agreement with Cellcom, Vubiquity will provide a full suite of content acquisition, curation, marketing and content management services – ensuring Cellcom TV viewers have access to best-in-class linear and video-on-demand content choices as part of a personalized digital experience.

“Cellcom TV provides our customers with the best content experience, with a rich on-demand service offering the most wanted movies and series, in addition to our Cellcom LIVE service,” said Dafna Agassi Bar, Chief Marketing Officer at Cellcom. “Renewing and strengthening our collaboration with Amdocs supports our vision of giving our viewers a truly world-class experience.”

“We’re delighted to build on our relationship with Cellcom and continue to bring compelling new content to its customers,” said Anthony Goonetilleke, Group President of Technology and Head of Strategy at Amdocs. “As streaming competition intensifies, this agreement exemplifies how Amdocs can enable service providers to create a personalized and differentiated digital offering.”

Supporting Resources

• Keep up with Amdocs news by visiting the company’s website
• Follow us on , Facebook, LinkedIn and YouTube

Amdocs’ Forward-Looking Statement
This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs’ filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2021 filed on December 10, 2021, and our Form 6-K furnished for the first quarter of fiscal 2022 on February 14, 2022, for the second quarter of fiscal 2022 on May 24, 2022 and for the third quarter of fiscal 2022 on August 15, 2022.

Media Contacts

Michael Youds
Amdocs Public Relations
Tel: +44 7855 827 038
Email: [email protected]    

Holly Abbott
Babel PR for Amdocs
Tel: +44 (0)7527 521057
Email: [email protected] / [email protected]   

[ Back To TMCnet.com's Homepage ]